Clinical study on the prevention and treatment of CRRT-associated hypophosphatemia with phosphorus replacement fluid

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046884

Enrollment

Unknown

Registered

2021-05-29

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Group 1:Supplement sodium glycerophosphate on the basis of conventional replacement fluid

Group 2:Conventional replacement fluid

Eligibility

Sex/Gender

All

Age

18 Years to 76 Years

Inclusion criteria

Inclusion criteria: 1. Patients with severe pancreatitis, sepsis, MODS, ARDS, cardiovascular surgery and acute kidney injury who need CRRT treatment; 2. Aged 18-76 years; 3. No gender limit; 4. Volunteer to participate in clinical research and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. CKD stage 5 patients undergoing regular dialysis; 2. Patients with intermittent CRRT or less than 12 hours per treatment; 3. Patients considered by the investigator to be inappropriate to participate in this study.

Design outcomes

Primary

Measure	Time frame
incidence of hypophosphatemia;	—

Secondary

Measure	Time frame
all-cause mortality;	—

Countries

China

Contacts

Public ContactLu Caibao

Xinqiao Hospital of Army Medical University

lucaibao@163.com+86 18908330833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026